Use of body mass index percentile to identify fat-free mass depletion in children with cystic fibrosis

2012 ◽  
Vol 31 (6) ◽  
pp. 927-933 ◽  
Author(s):  
Mariëlle P.K.J. Engelen ◽  
Ruth Schroder ◽  
Karin Van der Hoorn ◽  
Nicolaas E.P. Deutz ◽  
Gulnur Com
Keyword(s):  
Body Mass Index ◽  
Cystic Fibrosis ◽  
Body Mass ◽  
Fat Free Mass ◽  
Body Mass Index Percentile ◽  
Mass Depletion

Fat-free mass depletion in cystic fibrosis: Associated with lung disease severity but poorly detected by body mass index

Nutrition ◽  
2010 ◽  
Vol 26 (7-8) ◽  
pp. 753-759 ◽  
Author(s):  
Susannah J. King ◽  
Ibolya B. Nyulasi ◽  
Boyd J.G. Strauss ◽  
Tom Kotsimbos ◽  
Michael Bailey ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Cystic Fibrosis ◽  
Lung Disease ◽  
Disease Severity ◽  
Body Mass ◽  
Fat Free Mass ◽  
Mass Depletion ◽  
Lung Disease Severity

scholarly journals Nutrional status and dietary factors in cystic fibrosis patients with delta F508 mutation

2015 ◽  
Vol 28 (4) ◽  
pp. 359-369 ◽  
Author(s):  
Carina de Sousa SANTOS ◽  
Thais STEEMBURGO
Keyword(s):  
Body Mass Index ◽  
Cystic Fibrosis ◽  
Nutritional Status ◽  
Children And Adolescents ◽  
Body Mass ◽  
Energy Requirement ◽  
Prevalence Ratio ◽  
Dietary Factors ◽  
Lower Prevalence ◽  
Body Mass Index Percentile

Objective To examine the association between nutritional status and dietary factors in children and adolescents with cystic fibrosis that are carriers of delta F508 mutation. Methods Cross-sectional study of cystic fibrosis children and adolescents. Nutritional status (body mass index percentile) and dietary intake (3-day diet records presented as a percentage of estimated energy requirement) were assessed. Results Thirty six patients (median of 8.6; interquartile range 6.8-12.5 years; 50% male). The Poisson regression analysis showed that the carriers for delta F508 mutation had 60% lower prevalence ratio of body mass index ≥25° (PR=0.4; 95%IC=0.2-0.8) and 90% lower prevalence ratio (PR=0.1; confidence interval 95%IC=0.02-0.3) of ≥150% of estimated energy requirement when compared with non-delta F508 mutation carriers. The model was adjusted for lung function, estimated energy requirement, and body mass index. Conclusion Carriers for delta F508 mutation showed lower body mass index percentile and lower daily caloric consumption when compared with patients without this mutation.

scholarly journals Emotion Awareness Predicts Body Mass Index Percentile Trajectories in Youth

2015 ◽  
Vol 167 (4) ◽  
pp. 821-828.e4 ◽  
Author(s):  
Diana J. Whalen ◽  
Andy C. Belden ◽  
Deanna Barch ◽  
Joan Luby
Keyword(s):  
Body Mass Index ◽  
Body Mass ◽  
Body Mass Index Percentile

Body Weight and Body Mass Index in Patients with End-Stage Cystic Fibrosis Stabilize After the Start of Enteral Tube Feeding

2017 ◽  
Vol 117 (11) ◽  
pp. 1808-1815 ◽  
Author(s):  
Francis M. Hollander ◽  
Nicole M. de Roos ◽  
Gerdien Belle van Meerkerk ◽  
Ferdinand Teding van Berkhout ◽  
Harry G.M. Heijerman ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Cystic Fibrosis ◽  
Body Weight ◽  
Body Mass ◽  
Tube Feeding ◽  
Enteral Tube Feeding ◽  
End Stage

scholarly journals Assessment of the Non-Cystic Fibrosis Bronchiectasis Severity: The FACED Score vs the Bronchiectasis Severity Index

2015 ◽  
Vol 9 (1) ◽  
pp. 46-51 ◽  
Author(s):  
J Minov ◽  
J Karadzinska-Bislimovska ◽  
K Vasilevska ◽  
S Stoleski ◽  
D Mijakoski
Keyword(s):  
Body Mass Index ◽  
Cystic Fibrosis ◽  
Clinical Practice ◽  
Observational Study ◽  
Body Mass ◽  
Severity Index ◽  
Sufficient Power ◽  
Chronic Colonization ◽  
The Mean

Introduction : Non-cystic fibrosis bronchiectasis (NCFB) is a multidimensional disease, and no single isolated parameter is proved to have sufficient power for any overall determination of its severity and prognosis. Objective : To compare the results of the assessment of the NCFB severity with respect to its prognosis in the same patients by two different validated scores, i.e. the FACED score and the Bronchiectasis Severity Index (BSI). Methods : An observational study including 37 patients with NCFB (16 males and 21 female aged 46 to 76 years) was performed. All patients underwent evaluation of the variables incorporated in the FACED score (FEV1 % predicted, age, chronic colonization by Pseudomaonas aeruginosa, radiological extent of the disease, and dyspnea) and in the BSI (age, body mass index, FEV1 % predicted, hospitalization and exacerbations in previous year, dyspnea, chronic colonization by Pseudomaonas aeruginosa and other microrganisms, and radiological extent of the disease). Results : According to the value of the derived overall FACED score we found 17 patients (45.9%) with mild bronchiectasis, 14 patients (37.8%) with moderate bronchiectasis and 6 patients (16.2%) with severe bronchiectasis. The mean derived FACED score was 3.4 ± 1.3. In addition, according to the value of the derived overall BSI score, the frequency of patients with low, intermediate and high BSI score was 16 patients (43,2%), 14 patients (37.8%) and 7 patients (18.9%), respectively. The mean derived BSI score was 6.4 ± 2.5. Conclusion : We found similar results by the assessment of the NCFB severity in regard to its prognosis by both the FACED score and the BSI. Further studies determining how these scores may impact clinical practice are needed.

Sign in / Sign up

Export Citation Format

Share Document